Bioforce Announces Publication of an Important New Immune Support Study on Echinaforce
Bioforce Announces Publication of an Important New Immune Support Study on Echinaforce® in Phytomedicine Journal
Ghent, NY (PRWEB) August 20, 2011
The efficacy of Echinacea purpurea in supporting a healthy immune system is based on modulatory effects on immune function. There are many factors linked to short or long term weakening of the immune system, that reduce the body’s natural defenses. Stress, lack of sleep, poor diet all can compromise the immune system’s ability to respond. Since it has been largely unknown how this modulation manifests in the body, and how the effects develop in subjects with weaker immune response, the goal of this study was to monitor several immune mediators during Echinacea treatment. (Effects of Echinaforce® treatment on ex vivo-stimulated blood cells, M.R. Ritchie, J. Gertsch, P. Klein, R. Schoop, Phytomedicine 2011;18:826-831)
For the first time ex vivo study data demonstrated a prophylactic immunomodulation in the human body. In a clinical study conducted at the University of St. Andrews 30 volunteers were treated with Echinaforce® for 8 days. Various factors of the immune system were investigated during Echinaforce® treatment. Effects on individuals with strong immune response were compared with the effects in those with weak response.
The following effects were most prominent in phases of weak immune response in stressed and susceptible individuals:
Reinforcement of antiviral defense through interferon gamma was stimulated by Echinaforce®.
In individuals with a weak immune response the anti-inflammatory factor interleukin 10 was simulated by Echinaforce®. In contrast, initial high concentrations of the pro-inflammatory factors TNF-alpha and interleukin 1 were inhibited.
Immune cells mobilized by chemokines. The chemokines interleukin-8 and MCP-1 were stimulated in individuals with a weak immune response. These ensure migration of the immune cells to the site of infection.
Subjects whose immune cells showed initial “weak” immune reaction experienced exceptionally pronounced effects upon treatment. In contrast, there were no increased effects in subjects with a strong immune response. The authors chose the term “adaptive immune modulation” to describe the selective effects of Echinacea on subjects with weak immune response due to life situations causing short or long term weakening of the immune system.
Pierce Sioussat, President of Bioforce USA stated “Alfred Vogel, the Swiss Naturopath who founded Bioforce, saw that Echinacea had a wide spectrum of actions, with gentle, yet profound effects on the body. Bioforce has focused its research on understanding the power of this plant and how to best use it in supporting health. This latest study is another important step in that direction. We found this study of great interest because it once again proves that rather than stimulating the immune system, as once believed, Echinaforce® modulates the immune response only where and when needed, truly providing support for a healthy immune system.”
Bioforce USA is devoted to bringing health-minded Americans Europe’s most sophisticated, pharmaceutical-grade and proven products based on primary research. Natural products retailers who sell Bioforce USA product lines are providing their customers with products that meet the very strict European standards for pharmaceutical GMPs and cosmetic regulations, so consumers can be assured of product safety, efficacy, integrity and uniform standards of product quality.
For more information contact Eileen Sheets at 800-641-7555
###
Attachments
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
Finally, an issue that I am passionate about. I have looked for information of this caliber for the last several hours. Your site is greatly appreciated.